Co-occurrence of toxic bacterial and fungal secondary metabolites in moisture-damaged indoor environments

Author(s): Taubel M, Sulyok M, Vishwanath V, Bloom E, Turunen M, et al.

Abstract

Toxic microbial secondary metabolites have been proposed to be related to adverse health effects observed in moisture-damaged buildings. Initial steps in assessing the actual risk include the characterization of the exposure. In our study, we applied a multi-analyte tandem mass spectrometry-based methodology on sample materials of severely moisture-damaged homes, aiming to qualitatively and quantitatively describe the variety of microbial metabolites occurring in building materials and different dust sample types. From 69 indoor samples, all were positive for at least one of the 186 analytes targeted and as many as 33 different microbial metabolites were found. For the first time, the presence of toxic bacterial metabolites and their co-occurrence with mycotoxins were shown for indoor samples. The bacterial compounds monactin, nonactin, staurosporin and valinomycin were exclusively detected in building materials from moist structures, while chloramphenicol was particularly prevalent in house dusts, including settled airborne dust. These bacterial metabolites are highly bioactive compounds produced by Streptomyces spp., a group of microbes that is considered a moisture damage indicator in indoor environments. We show that toxic bacterial metabolites need to be considered as being part of very complex and diverse microbial exposures in 'moldy' buildings.

Practical implications: Bacterial toxins co-occur with mycotoxins in moisture-damaged indoor environments. These compounds are measurable also in settled airborne dust, indicating that inhalation exposure takes place. In attempts to characterize exposures to microbial metabolites not only mycotoxins but also bacterial metabolites have to be targeted by the analytical methods applied. We recommend including analysis of samples of outdoor air in the course of future indoor assessments, in an effort to better understand the outdoor contribution to the indoor presence of microbial toxins. There is a need for a sound risk assessment concerning the exposure to indoor microbial toxins at concentrations detectable in moisture-damaged indoor environments.

Similar Articles

The diagnosis and incidence of allergic fungal sinusitis

Author(s): Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, et al.

Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis

Author(s): Ponikau JU, Sherris DA, Kita H, Kern EB

Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis

Author(s): Ponikau JU, Sherris DA, Kephart GM, Kern EB, Congdon DJ, et al.

Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies

Author(s): Chakrabarti A, Denning DW, Ferguson BJ, Ponikau J, Buzina W, et al.

'Eosinophilic fungal rhinosinusitis': a common disorder in Europe? Laryngoscope 113: 264-269

Author(s): Braun H, Buzina W, Freudenschuss K, Beham A, Stammberger H

Allergic Aspergillus sinusitis: a newly recognized form of sinusitis

Author(s): Katzenstein AL, Sale SR, Greenberger PA

Chronicrhinosinusitis: an enhanced immune response to ubiquitous airborne fungi

Author(s): Shin SH, Ponikau JU, Sherris DA, Congdon D, Frigas E, et al.

Aspergillosis of the nose and paranasal sinuses

Author(s): Milroy CM, Blanshard JD, Lucas S, Michaels L

Localised invasive sino-orbital aspergillosis: characteristic features

Author(s): Sivak-Callcott JA, Livesley N, Nugent RA, Rasmussen SL, Saeed P, et al.

Killing of Aspergillusfumigatus by alveolar macrophages is mediated by reactive oxidant intermediates

Author(s): Philippe B, Ibrahim-Granet O, Prévost MC, Gougerot-Pocidalo MA, Sanchez Perez M, et al.

Aspergillosis of the sphenoid sinus simulating a pituitary tumor

Author(s): Larranaga J, Fandiño J, Gomez-Bueno J, Rodriguez D, Gonzalez-Carrero J, et al.

Allergic aspergillus sinusitis with proptosis

Author(s): Daghistani KJ, Jamal TS, Zaher S, Nassif OI

New species in Aspergillus section Terrei

Author(s): Samson RA, Peterson SW, Frisvad JC, Varga J

A water-damaged home and health of occupants: a case study

Author(s): Thrasher JD, Gray MR, Kilburn KH, Dennis DP, Yu A

Molds and mycotoxins in indoor environments--a survey in water-damaged buildings

Author(s): Bloom E, Nyman E, Must A, Pehrson C, Larsson L

Trichothecenemycotoxins in the dust of ventilation systems in office buildings

Author(s): Smoragiewicz W, Cossette B, Boutard A, Krzystyniak K

Mycotoxins in crude building materials from water-damaged buildings

Author(s): Tuomi T, Reijula K, Johnsson T, Hemminki K, Hintikka EL, et al.

Expression of markers shared between human haematopoietic cells and neuroblastoma cells

Author(s): Ebener U, Wehner S, Cinatl J, Gussetis ES, Kornhuber B

Leukophysin: a 28-kDa granule membrane protein of leukocytes

Author(s): Abdelhaleem MM, Hatskelzon L, Dalal BI, Gerrard JM, Greenberg AH

Pathogenesis II: fungal responses to host responses: interaction of host cells with fungi

Author(s): Mendes-Giannini MJ, Taylor ML, Bouchara JB, Burger E, Calich VL, et al.

Detection of fungal organisms in eosinophilicmucin using a fluorescein-labeled chitin-specific binding protein

Author(s): Taylor MJ, Ponikau JU, Sherris DA, Kern EB, Gaffey TA, et al.

Mycotoxin detection in human samples from patients exposed to environmental molds

Author(s): Hooper DG, Bolton VE, Guilford FT, Straus DC

A water-damaged home and health of occupants: a case study

Author(s): Thrasher JD, Gray MR, Kilburn KH, Dennis DP, Yu A

Aspergillus bronchitis without significant immunocompromise

Author(s): Chrdle A, Mustakim S, Bright-Thomas RJ, Baxter CG, Felton T, et al.

Aspergillusterreus complex: an emergent opportunistic agent of Onychomycosis

Author(s): Fernandez MS, Rojas FD, Cattana ME, Sosa Mde L, Mangiaterra ML, et al.

Invasive Aspergillusterreus sinusitis with orbitocranial extension: case report

Author(s): Akhaddar A, Gazzaz M, Albouzidi A, Lmimouni B, Elmostarchid B, et al.

Clinical features and outcomes of four patients with invasive fungal sinusitis

Author(s): Takahashi H, Hinohira Y, Hato N, Wakisaka H, Hyodo J, et al.

Detection of mycotoxins in patients with chronic fatigue syndrome

Author(s): Brewer JH, Thrasher JD, Straus DC, Madison RA, Hooper D

Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged buildings

Author(s): Gray MR, Thrasher JD, Crago R, Madison RA, Arnold L, et al.

Fungal rhinosinusitis and imaging modalities

Author(s): Gorovoy IR, Kazanjian M, Kersten RC, Kim HJ, Vagefi MR